Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Common Equity (2016 - 2025)

InspireMD (NSPR) has 16 years of Common Equity data on record, last reported at $64.1 million in Q3 2025.

  • For Q3 2025, Common Equity rose 55.05% year-over-year to $64.1 million; the TTM value through Sep 2025 reached $64.1 million, up 55.05%, while the annual FY2024 figure was $36.1 million, 8.65% down from the prior year.
  • Common Equity reached $64.1 million in Q3 2025 per NSPR's latest filing, up from $20.2 million in the prior quarter.
  • Across five years, Common Equity topped out at $64.1 million in Q3 2025 and bottomed at $13.4 million in Q1 2023.
  • Average Common Equity over 5 years is $35.0 million, with a median of $36.1 million recorded in 2024.
  • Peak YoY movement for Common Equity: surged 1164.14% in 2021, then tumbled 56.71% in 2025.
  • A 5-year view of Common Equity shows it stood at $33.5 million in 2021, then plummeted by 48.13% to $17.4 million in 2022, then skyrocketed by 127.11% to $39.5 million in 2023, then fell by 8.65% to $36.1 million in 2024, then skyrocketed by 77.67% to $64.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Common Equity were $64.1 million in Q3 2025, $20.2 million in Q2 2025, and $28.3 million in Q1 2025.